Treating Yourself- Medical Marijuana - Marco Rendo - Issue 5 (Part 2).pdf

(7619 KB) Pobierz
PSILOCYBIN
Psilocybin
(Magic) Mushrooms' Medical Benefits
Warning/disclaimer: Do not consume any psychedelics such as
psilocybin mushrooms if you have emotional or psychological
upheaval in your life, schizophrenia, or early onset of mental ill-
ness. Do not operate any type of vehicles. Do not drive. If you
are prescribed any medications with MAOI (harmine and harma-
line), often found in prescription anti-depressants, check with
your doctor if you are not 100% sure. Sixty-five percent of psilo-
cybin is excreted in the urine within eight hours of ingestion,
with the rest taking weeks to leave the body.
medical cannabis. I found it strange and disheartening. Yes,
psilocybin mushrooms do have medical qualities; there are
many studies old and new with credible scientific facts proving
it, from relieving neurovascular headaches (cluster headaches)
to obsessive-compulsive disorder (OCD) to anxiety in the dying
to a mystical/religious experience, with some people still feeling
upbeat months later. Psilocybin is one of the least toxic of cur-
rently studied hallucinogens. Potential for physical addiction
and/or dependence is generally minimal, if at all.
The following article was constructed from interviews with Grant
W. Krieger, founder of the Grant W. Krieger Cannabis Research
Foundation (http://KriegerFoundation.com), Krieger Foundation
members with medical psilocybin mushrooms experiences, my
own experiences (30+ years), credible books, and the Internet.
A double blind study was completed, with very interesting
results, at Johns Hopkins School of Medicine, led by Roland R.
Griffiths, published in Psychopharmacology: “Sixty-one percent
of subjects reported a ‘complete mystical experience’ after their
psilocybin session, while only 13% reported such an outcome
after their experience with methylphenidate [Ritalin]. Two
months after taking psilocybin, 79% of the participants report-
ed moderately to greatly increased life satisfaction and sense of
well-being.”
Grant W. Krieger Cannabis Research Foundation has been doing
many years of medical cannabis and medical mushroom
research, with a large number of medical-needs people.
When the topic of writing an article on psilocybin mushrooms’
medical qualities was brought up on the TreatingYourself.com
website, there were many closed-minded people wanting to
stop the article from being published. Surprisingly, these same
people have suffered the exact same attitudes in regards to
The human body needs proper rest/sleep to function properly,
which includes healing itself. Despite a common belief, rapid
eye movement (REM) sleep is not the best sleep for the human
body. During the REM sleep stage, the activity of the brain is
similar to that during waking hours. The deepest and most reju-
60
TY Issue 5
1051840991.016.png 1051840991.017.png 1051840991.018.png 1051840991.019.png
 
1051840991.001.png
venating stage of sleep is the Delta sleep stage. Delta sleep is
essential for a human body to function properly. A small amount
of psilocybin will help the body enter Delta sleep easier and for
longer periods of time.
One of the many people Krieger worked with was an elderly
gentleman over 80 years old. He was stricken with cancer in pal-
liative care, incapacitated in a wheelchair, and unable to do any-
thing on his own. He couldn’t speak and drooled uncontrollably.
Additionally, he was a double-leg amputee at the knees as a
teenager but was able to use artificial legs for most of his adult
life. His caregiver (daughter) was dead-set against cannabis, let
alone psilocybin mushrooms. After Krieger properly educated
the daughter she agreed to try a natural way of helping her
father.
Krieger suggests a person take .05 grams (amounts vary
depending on each individual) at the exact same time every
night 30 to 40 minutes before bedtime. The reason for this is
to establish a rhythm (reset the human body’s biological clock
if you will). As each week passes the dose is increased by a
small amount over a period of time. Each person is different, of
course, so the amounts and lengths of time (days, weeks) have
to be adjusted accordingly.
Krieger gave her strict instructions to administer cannabis but-
ter and psilocybin mushrooms daily at the same time everyday
without fail. One month later, when Krieger returned for a visit,
the elderly man was able to sit up properly and carry on a con-
versation; however, he was still in somewhat of a fog due to the
prescribed pharmaceutical medication morphine. After 3
months, on a return visit, the elderly man had blisters on the
stumps of his legs. Krieger asked what happened. The elderly
man proudly told Krieger that he was able to put on his artifi-
This happens by turning off the serotonergic neurons’ filtering
of information while you’re awake. The same effect happens nat-
urally when you enter Delta sleep, which is why humans tend to
dream. The brain’s medial temporal lobe is rich in serotonin
synapses. Psilocybin affects the 5HT2 receptor in particular and
alters states of consciousness. The serotonin system (5-HT) is
one of the most important and largest of the brain’s synaptic
chemical messengers. Serotonin synapses in the brain control
functions like sleep, mood, and general arousal.
“Krieger gave her strict
instructions to administer
cannabis butter and psilo-
cybin mushrooms daily at
the same time everyday with-
out fail. One month later,
when Krieger returned for
a visit, the elderly man was
able to sit up properly and
carry on a conversation;
however, he was still in
somewhat of a fog due to
the prescribed pharmaceuti-
cal medication morphine.”
cial legs for the first time in many years and walk around the
house and go on short walks. He had also gone shopping with
his daughter, walking the whole length of a large shopping mall.
“I’ll just have to toughen up my stumps again,” the elderly man
proudly announced. Additionally, he was slowly cutting back on
his prescribed pharmaceutical medications. After 4 months the
elderly man was wrestling on the floor with his grandchildren
and was able dance at both of his sons’ weddings. The daugh-
ter decides to tell the father’s doctor what has actually made
the incredible improvements in her father’s health. The doctor
convinces the daughter to stop the cannabis butter and psilo-
61 TY Issue 5
 
1051840991.002.png 1051840991.003.png 1051840991.004.png 1051840991.005.png 1051840991.006.png
PSILOCYBIN
cybin mushroom treatments immediately. The elderly man died
two weeks later.
a hangover in the morning, whereas the psilocybin mushroom
didn’t. The mushrooms actually gave her a more upbeat feeling
the next day and she was able to function better.
Another person Krieger worked with was a dying lady (medical
doctors’ opinion), incapacitated in a wheelchair unable to do
anything, with multiple sclerosis. Krieger had her on cannabis
Bert is also on psilocybin mushroom therapy and consumes
cannabis butter for medical reasons. He was injured in an indus-
butter and .05 of a gram of psilocybin mushrooms for one
month. After the month, the lady was able to get 4 hours of
Delta sleep each night. The woman’s husband (caregiver) took
Krieger aside and asked him, “Are you performing black magic
in my home?” With his wife being able to sleep, and him final-
ly getting rest, the couple’s health seemed to be improving
already. During the second month, the dose of psilocybin mush-
rooms was doubled to .1 gram and the lady’s Delta sleep
increased to at least 6.5 hours per night. The third month there
was another increase in the dose of psilocybin mushrooms.
Afterwards, the couple was getting at least 8 hours of sleep
each night. Six months later, with massage therapy added, the
lady was walking around and able to enjoy a quality life once
again. She was eventually able to end the psilocybin mushroom
dose and massage therapy for 18 months before having to go
back on the mushroom therapy for a period of time.
trial accident. Before starting cannabis and psilocybin mush-
room therapy he had to sleep sitting up in a chair and was only
getting an hour of sleep at a time, at best, due to his pain. He
wouldn’t take pharmaceutical sleeping pills because he has two
family members who have physical addictions to them. The first
time Bert met Krieger, he noticed some serious issues with Bert
right away. After having a conversation and physically checking
him, Krieger recommended cannabis butter, psilocybin mush-
rooms, and massage therapy. Bert was desperate and immedi-
ately agreed to try Krieger’s recommendations. On his way home
with a free supply of cannabis butter and psilocybin mushrooms
given to him by Krieger, he was stopped by the RCMP and
charged with possession of cannabis and psilocybin mush-
rooms. Krieger had his lawyer call the crown prosecutor and the
charges were dropped before a trial could even begin. Why were
the charges dropped? It was medicinal use of cannabis and
psilocybin mushrooms.
Another elderly lady seemed to grow an inch, even though the
elderly don’t grow. Krieger explained that it was due to the
cannabis butter, psilocybin mushrooms, and massage therapy,
which allowed the muscles to relax and the back to straighten
up properly.
I have included a quote told to me from a non-cannabis con-
sumer suffering from obsessive-compulsive disorder (OCD). “If I
can do 1 to 2 grams of psilocybin mushrooms every 4 or 5 days
I do not suffer from obsessive-compulsive disorder effects.”
Here are two more examples (both Donna and Bert started their
mushroom therapy at 0.5 g):
Keith Fagin
Calgary 420 Cannabis Community Founder
http://Calgary420.ca/
Donna (Sedative Ocean) is on psilocybin mushroom therapy and
consumes cannabis butter for medical reasons. Donna found it
took about 7 to 10 days to adjust to a schedule. Within one
month she felt her biological clock had been reset properly,
because she was sleeping normally. Donna had used pharma-
ceutical sleeping pills in the past but found that they gave her
Editors Note: Everyone’s entitled to his/her opinion! That said I
would have to disagree with Keith about all TY members being
against our Mushroom Feature. Only a handful was against it
and not the majority of the TY online community.
62
TY Issue 5
1051840991.007.png 1051840991.008.png
 
1051840991.009.png
 
1051840991.010.png 1051840991.011.png 1051840991.012.png
PSILOCYBIN
Psilocybin
as Medicine in the
Twenty-First Century
Ban Phang Ka
T
here has been a long history of the use of low doses
of potentially psychedelic drugs for the treatment of
a wide array of physiological and psychological con-
ditions. There are several over-the-counter remedies
that qualify, like Dramamine, Benedryl, and dex-
tromethorphan, which are respectively used to treat
nausea, allergies, and cough. More frequently, drugs that quali-
fy are only provided through prescription. For example, the ergot
alkaloid ergonovine and its synthetic analog methylergonovine
are both used in obstetrics because of their oxytocic properties.
At doses approximately ten times those utilized for their medical
uses, the five chemicals listed above produce disassociating and
psychedelic effects, respectively. Another class of drugs used in
psychiatry, with a history of use as psychedelics, is the
monoamine oxidase inhibitors (MAOIs), which are commonly pre-
scribed to treat depression.
Despite these observations, many of our readers might be startled
to learn that the psychedelic indolamine psilocybin has been sug-
gested to be beneficial for a variety of medical conditions.
Psilocybin is the more stable of the two primary active chemicals in
psychedelic mushrooms. The FDA has approved two preliminary
studies into the use of psilocybin. One study is investigating treat-
ing obsessive-compulsive disorder (OCD) with psilocybin. The other
study is testing psilocybin’s ability to reduce physical pain, and the
anxiety and depression associated with fear of dying in stage IV
cancer patients. Researchers at Harvard Medical School are current-
ly seeking approval for a third study into the even more promising
use of sub-recreational doses of psilocybin and LSD25 as treat-
ments for cluster headaches. These three preliminary studies,
backed by a troop of case reports, may potentially open the door
for future clinical trials into therapeutic uses of psilocybin.
64
TY Issue 5
1051840991.013.png 1051840991.014.png 1051840991.015.png
Zgłoś jeśli naruszono regulamin